Benitec Biopharma Inc. logo

Benitec Biopharma Inc.

BNTC | NASDAQ
Chart Builder DCF Calculator
$10.88
-$0.14 (-1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$10.88
$0 (0.00%)
After-hours: Sep 21, 2026, 4:10 PM ET
Fiscal Quarter
Period Ending
Q4 2026
Jun 29, 2026
Q3 2026
Mar 30, 2026
Q2 2026
Dec 30, 2025
Q1 2026
Sep 29, 2025
Q4 2025
Jun 29, 2025
Q3 2025
Mar 30, 2025
Q2 2025
Dec 30, 2024
Q1 2025
Sep 29, 2024
Q4 2024
Jun 29, 2024
Q3 2024
Mar 30, 2024
Q2 2024
Dec 30, 2023
Q1 2024
Sep 29, 2023
Q4 2023
Jun 29, 2023
Q3 2023
Mar 30, 2023
Q2 2023
Dec 30, 2022
Q1 2023
Sep 29, 2022
Q4 2022
Jun 29, 2022
Q3 2022
Mar 30, 2022
Q2 2022
Dec 30, 2021
Q1 2022
Sep 29, 2021
Q4 2021
Jun 29, 2021
Q3 2021
Mar 30, 2021
Q2 2021
Dec 30, 2020
Q1 2021
Sep 29, 2020
Revenue
n/a n/a n/a n/a 556K n/a n/a n/a -6K n/a n/a n/a 7K 54K 14K n/a n/a 48K 25K n/a 2K 1K 1K 55K
Cost of Revenue
124K 119K 120K 118K 278K 106K 81K 91K 15K -3K 1K -106K 84K n/a 41K 102K 9K n/a n/a 102K 1K 7K -19K 134K
Gross Profit
-124K -119K -120K -118K 278K -106K -81K -91K -21K 3K -1K 106K 7K 54K 14K -102K -9K 48K 25K -102K 1K -6K 20K -79K
Operating Income
-14.43M -13.58M -13.38M -9.8M -9.83M -15.34M -10.81M -5.79M -5.55M -4.14M -6.93M -5.87M -4.55M -4.34M -5.61M -4.58M -4.74M -3.46M -4.84M -4.82M -3.86M -3.79M -3.26M -2.69M
Interest Income
1.57M 1.59M n/a n/a n/a 823K 823K n/a 920K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-12.81M -11.94M -11.84M -8.97M -8.81M -14.5M -9.55M -5.06M -4.72M -4.28M -6.8M -5.95M -4.66M -4.4M -5.41M -5.09M -5.07M -3.28M -4.82M -5.05M -4M -3.91M -3.25M -2.72M
Net Income
-12.81M -11.94M -11.84M -8.97M -16.15M -14.5M -9.55M -5.06M -4.72M -4.28M -6.8M -5.95M -4.66M -4.4M -5.41M -5.09M -5.07M -3.28M -4.82M -5.05M -4M -3.91M -3.25M -2.72M
Selling & General & Admin
6.54M 7.28M 7.54M 6.43M 13.48M 8.84M 5.42M 2.21M 2.04M 1.58M 1.82M 1.55M 1.37M 1.23M 1.86M 1.92M 1.55M 1.34M 1.71M 2.04M 1.54M 1.03M 2.11M 1.84M
Research & Development
9.61M 6.3M 5.83M 3.37M 3.7M 6.5M 5.39M 3.59M 3.51M 2.57M 5.1M 4.43M 3.19M 3.17M 3.76M 2.66M 3.18M 2.17M 3.15M 2.78M 2.32M 2.76M 1.17M 774K
Other Expenses
-1.85M -119K -120K -153.72K -7.46M -106K -81K -91K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
14.31M 13.46M 13.26M 9.65M 9.72M 15.23M 10.72M 5.7M 5.55M 4.14M 6.93M 5.98M 4.56M 4.4M 5.62M 4.58M 4.73M 3.51M 4.86M 4.82M 3.86M 3.79M 3.28M 2.61M
Interest Expense
n/a n/a -1.39M -1.01M -1.04M n/a n/a -604K n/a 4K 6K 6K 8K 7K 9K 9K 10K 10K 11K 1K 1K 2K 2K 1K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
14.43M 13.58M 13.38M 9.8M 9.83M 15.34M 10.81M 5.79M 5.55M 4.14M 6.93M 5.87M 4.56M 4.4M 5.62M 4.58M 4.74M 3.51M 4.86M 4.82M 3.86M 3.79M 3.26M 2.75M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
46.56M 49.39M 45.97M 41.52M 36.21M 38.6M 22.08M 10.64M 10.09M 10.44M 10.3M 8.63M 6.58M 1.65M 6.48M 2.55M 1.92M 1.92M 1.92M 1.92M 1.66M 1.12M 1.01M 260.79K
Shares Outstanding (Diluted)
46.56M 49.39M 45.97M 41.52M 36.21M 38.6M 22.08M 10.64M 10.09M 10.47M 10.31M 8.63M 6.58M 1.65M 6.49M 2.55M 1.92M 1.92M 1.92M 1.92M 1.66M 1.12M 1.01M 260.79K
EPS (Basic)
-0.27 -0.24 -0.26 -0.21 -0.39 -0.38 -0.33 -0.48 -0.53 -0.23 -0.54 -0.60 -1.41 -2.67 -0.20 -0.47 -5.27 -0.40 -0.59 -0.62 -4.82 -0.82 -0.76 -9.02
EPS (Diluted)
-0.27 -0.24 -0.26 -0.21 -0.39 -0.38 -0.33 -0.48 -0.53 -0.23 -0.54 -0.60 -1.41 -2.67 -0.20 -0.47 -5.27 -0.40 -0.59 -0.62 -4.82 -7 -0.76 -9.02
EBITDA
-14.31M -13.46M -13.26M -9.69M -17.06M -15.23M -10.72M -5.7M -5.38M -4.05M -6.71M -5.79M -4.57M -4.3M -5.3M -4.98M -4.99M -3.15M -4.7M -4.94M -3.75M -3.79M -3.14M -2.6M
EBIT
-14.43M -13.58M -13.38M -9.8M -17.18M -15.34M -10.81M -5.79M -5.48M -4.14M -6.79M -5.87M -4.65M -4.39M -5.4M -5.08M -5.06M -3.27M -4.81M -5.04M -3.86M -3.91M -3.25M -2.69M
Depreciation & Amortization
124K 119K 120K 118K 118K 106K 81K 91K 91K 90K 80K 82K 84K 93K 102K 102K 63K 114K 113K 102K 102K 115K 115K 92K

© 2026 bestshares.com. All rights reserved.